Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05935826 · ClinicalTrials.gov registry record · Phase 3
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
A Phase 3 study of NAFLD and Adolescent Obesity, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT05935826 is a Phase 3 study of NAFLD and Adolescent Obesity that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 55 participants, below the 163-participant average among 26 other NAFLD trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05935826, a Phase 3 study of NAFLD and Adolescent Obesity, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants 13-18 years of age with extra fat stored in the liver will be randomly assigned to a protein supplement or placebo "fake supplement" for 2 months to see if the participants who get the protein supplement have less fat in the liver compared to participants who were in the placebo group. After the 2 month intervention, all participants can continue the study and will all receive the protein supplement for an additional 10-months.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Essential Amino Acid Supplement by Amino Co
Study Locations (1)
Colorado
- Univeristy of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2026-08-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05935826
The ClinicalTrials.gov registry entry for NCT05935826 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 163-participant average among 26 other NAFLD trials with a reported enrollment target (66% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with NAFLD appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05935826 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05935826 about?
NCT05935826 is a clinical study titled "Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)". Participants 13-18 years of age with extra fat stored in the liver will be randomly assigned to a protein supplement or placebo "fake supplement" for 2 months to see if the participants who get the protein supplement have less fat in the liver compared to participants who were in the placebo group. ...
What is the current status of trial NCT05935826?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 55 participants. The study started on 2024-06-18. Estimated completion is 2026-08-31.
What conditions does trial NCT05935826 study?
This clinical trial studies the following conditions: NAFLD, Adolescent Obesity, Hepatic Steatosis.
What interventions are being tested in trial NCT05935826?
The interventions under investigation include: Placebo (OTHER), Essential Amino Acid Supplement by Amino Co (DRUG).
Who is sponsoring clinical trial NCT05935826?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05935826 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
RECRUITING
-
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
RECRUITING · Phase 2
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
Digoxin In NASH (CODIN)
RECRUITING · Phase 2
-
Bicalutamide Therapy in Young Women With NAFLD and PCOS
RECRUITING · Phase 1
-
Androgens and NAFLD Longitudinal Cohort Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.